Use of nanotechnology for the development of novel cancer biomarkers

Expert Review of Molecular Diagnostics

Volumn 6, Issue 5, 2006, Pages 679-683

  Banerjee, Hirendra Nath ^a   Verma, Mukesh ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Microarray; Nanomedicine; Raman spectroscopy; Surface enhanced laser desorption ionization

Indexed keywords

MOLECULAR MARKER; NANOCHANNEL; NANOWIRE; TUMOR MARKER;

BIOCHIP; BIOSENSOR; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; GENE MUTATION; GENOMIC INSTABILITY; GENOMICS; HEMATOLOGIC MALIGNANCY; HUMAN; MATERIAL STATE; MICROARRAY ANALYSIS; NANOCANTILEVER; NANOTECHNOLOGY; PROTEOMICS; RAMAN SPECTROMETRY; REVIEW; SIGNAL TRANSDUCTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TARGET ORGAN;

ANIMALS; BIOSENSING TECHNIQUES; HUMANS; MASS SPECTROMETRY; NANOTECHNOLOGY; NEOPLASMS; SPECTRUM ANALYSIS, RAMAN; TUMOR MARKERS, BIOLOGICAL;

EID: 33749525014     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.6.5.679     Document Type: Review

References (26)

1. Segal NH, Pavlidis P, Antonescu CR et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am. J. Pathol. 163(2), 691-700 (2003).
2. Chou WH, Yan FX, Robbins-Weilert DK et al. Comparison of two CYP2D6 genotyping methods and assessment of genotype-phenotype relationships. Clin. Chem. 49(4), 542-551 (2003).
3. Ferrari M, Stenirri S, Bonini P, Cremonesi L. Molecular diagnostics by microelectronic microchips. Clin. Chem. Lab. Med. 41(4), 462-467 (2003).
4. Borsting C, Sanchez JJ, Morling N. Multiplex PCR, amplicon size and hybridization efficiency on the NanoChip electronic microarray. Int. J. Leg. Med. 118(2), 75-82 (2004).
5. Dyrskjot L. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of micoarrays in cancer diagnostics. Exp. Rev. Mol. Diagn. 3(5), 635-647 (2003).
6. Van't Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415(6871), 530-536 (2002).
7. Workman P. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies and molecular chaperones. Cancer Chemother. Pharmacol. 52(Suppl. 1), 45-56 (2003).
8. Jez JM, Chen JC, Rastelli G, Stroud RM, Santi DV. Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90. Chem. Biol. 10(4), 361-368 (2003).
9. Staudt LM. Molecular diagnosis of the hematologic cancers. N. Engl. J. Med. 348(18), 1777-1785 (2003).
10. Koopmann J, Zhang Z, White N et al. Serum diagnosis of pancreatic adenocarinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin. Cancer Res. 10(3), 860-868 (2004).
11. Cooksey RC, Limor J, Morlock GP, Crawford JT. Identifying Mycobacterium species and strain typing using a microfluidic labchip instrument. Biotechniques 35(4), 786-794 (2003).
12. Jain KK. Nanodiagnostics: application of nanotechnology in molecular diagnostics. Exp. Rev. Mol. Diagn. 3(2), 153-161 (2003).
13. Madoz-Gurpide J, Hanash SM. Molecular analysis of cancer using DNA and protein microarrays. Adv. Exp. Med. Biol. 532, 51-58 (2003).
14. Kohlmann A, Schoch C, Schnittger S et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer 37(4), 396-405 (2003).
15. Pirollo KF, Dagata J, Wang P et al. A tumor targeted nanodelivery system to improve early MRI detection of cancer. Mol. Imaging 5(1), 41-52 (2006).
16. Leary SP, Liu CY, Apuzzo ML. Toward the emergence of nanoneurosurgery: part II - nanomedicine: diagnostics and imaging at the nanoscale level. Neurosurgery 58(5), 805-823 (2006).
17. Park W, Owens JM. Future directions in the treatment of oral cancer. Otolaryngol. Clin. North Am. 39(2), 381-396 (2006).
18. Manyak MJ, Jayitt M, Kang PS, Kreuger WR, Storm ES. The evolution of imaging in advanced prostate cancer. Urol. Clin. North Am. 33(2), 133-146 (2006).
19. Wiestner A, Rosenwald A, Barry TS et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101(12), 4944-4951 (2003).
20. Cheok MH, Yang W, Pui CH et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat. Genet. 34, 85-90 (2003).
21. Nishizuka S, Charboneau L, Young L et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA 100(24), 14229-14234 (2003).
22. Wulfkuhle JD, Aquino JA, Calvert VS et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics 3(11), 2085-2090 (2003).
23. Banerjee H, Hawkins Z, Williams J et al. Search for a novel biomarker for the brain cancer Astrocytoma by using surface enhanced laser desorption/ionization (SELDI) technique.Cell. Mol. Bio. 50(6), 733-736 (2004).
24. Sigurdsson S, Philipsen PA, Hansen LK, Larsen J, Gniadecka M, Wulf HC. Detection of skin cancer by classification of Raman spectra.IEEE Trans. Biomed. Eng. 51(10), 1784-1793 (2004).
25. Chang YR, Hsu L, Chi S. Optical trapping of a spherically symmetric sphere in the rayoptics regime: a model for optical tweezers upon cells. Appl. Opt. 45(16), 3885-3892 (2006).
26. The eSensor™ Biochip, Motorola Life Sciences, Pasadena, CA, USA. www.motorola.com/lifesciences/esencor/pr oducts_biochips.html